S&P/ASX 200 Index (ASX: XJO) shares are just inside the green on Tuesday as the market awaits the next interest rate announcement at 2:30pm.
Analysts are pricing in a 92% bet that the Reserve Bank of Australia (RBA) will lift the cash rate by 0.25% to 4.6%.
Persistently high inflation, rising oil prices due to the Iran-US conflict, soaring bond yields to multi-decade highs, and rock-bottom productivity growth in Australia are among the reasons interest rates are expected to rise again.
Experts say there could even be another 0.25% bump in November, which would be the fifth in the 2026 calendar year.
Meanwhile, experts offer their ratings and thoughts on three ASX 200 shares.
Image source: Getty Images
Woodside Energy Group Ltd (ASX: WDS)
The Woodside share price is $31.21, down 1.8% today and up 33% over 12 months.
John Athanasiou from Red Leaf Securities has a buy rating on this ASX 200 energy share.
Athanasiou said (courtesy of The Bull):
Woodside offers exposure to recent elevated global energy prices amid supply disruptions and continuing Middle East tensions.
Stronger realised prices should support near term cash flow and dividends.
A major risk is an easing of geopolitical tensions and a corresponding fall in crude oil prices.
However, the company delivered a solid interim result. Operating revenue of $7.446 billion in the first half of 2026 was up 13 per cent on the prior corresponding period. Underlying net profit after tax of $1.334 billion was up 7 per cent.
The Scarborough energy project is almost completed.
Ramsay Health Care Ltd (ASX: RHC)
The Ramsay Health Care share price is $55.77, up 0.4% today and up 77% over 12 months.
Morgans has a hold rating on this ASX 200 healthcare share.
The broker said:
Ramsay Santé's Capital Markets Day provided detail on its new "Connecting Care 2030" strategy ahead of the proposed demerger from RHC.
The strategy targets 2-3% revenue growth and stable EBITDA margins in FY27, followed by c3% revenue growth and gradual margin improvement to FY29.
While we view the strategy as credible, the outlook points to gradual rather than significant earnings growth, with tariff constraints remaining a key headwind.
For RHC shareholders, the proposed in-specie distribution should simplify the group and provide direct ownership of Santé through ASX-tradeable CDIs.
Life360 Inc (ASX: 360)
The Life360 share price is $18.95, down 1.9% today and down 64% over 12 months.
Michael Gable from Fairmont Equities has a sell rating on this ASX 200 tech share.
Gable commented:
The company posted a 38 per cent increase in revenue in the second quarter of 2026 when compared to the prior corresponding period. Total subscription revenue was up 31 per cent.
However, the share price has fallen from $29.48 on August 10 to trade at $19.44 on September 24.
We believe the business is vulnerable to increasing competition. Any earnings disappointments moving forward may further pressure the share price.
Investors may want to consider cashing in some gains.
